OrthoSphere — GPT-5.6 Evidence Brief

The description states that OrthoSphere is an assistive orthopaedic intelligence platform. It includes:

• OrthoPath, a deterministic clinical decision-support rules engine.
• OrthoRAG, a citation-oriented evidence retrieval layer.
• A GPT-5.6 Evidence Brief feature introduced during OpenAI Build Week.

The GPT-5.6 Evidence Brief is described as:

• Producing structured output based on a question and retrieved evidence.
• Including areas of agreement, uncertainty, limitations, missing context, and citation-linked claims.
• Being isolated from other components like OrthoPath.
• Using a strict JSON schema via the OpenAI Responses API.
• Enforcing safety controls to avoid generating clinical recommendations or diagnoses.

The platform also includes:

• Authenticated web and API services.
• PostgreSQL and pgvector infrastructure.
• Server-side handling of OpenAI API keys.
• Feature flags, rate limits, and deterministic regression tests.

Not evidenced There is no evidence of actual product usage, customer feedback, or deployment beyond the author’s development work. No mention of real users, clinical workflows, or integration into existing systems.

The description states that OrthoSphere was built to support orthopaedic clinicians who work across fragmented information sources and face challenges in organizing, assessing, and communicating evidence under time pressure.

It positions itself as:

• An assistive tool, not a replacement for clinical judgment.
• Designed to make evidence easier to inspect rather than to make treatment decisions.
• With a strong emphasis on safety boundaries—explicitly rejecting diagnostic or procedural prompts before model invocation.

The evolution of the product is described as:

• Starting with OrthoPath and OrthoRAG.
• Adding GPT-5.6 Evidence Brief during OpenAI Build Week.
• Maintaining architectural isolation between components.
• Focusing on structured output, citation grounding, uncertainty awareness, and safety validation.

Not evidenced No claims about market positioning, competitive differentiation, or strategic direction beyond the author’s personal development goals are provided.

The description states that OrthoSphere targets orthopaedic clinicians, including surgeons working in fragmented clinical environments. These users are said to struggle with organizing and assessing evidence under time pressure.

The description does not contain any information about:

• Revenue streams.
• Pricing models.
• Monetization strategy.
• Subscription tiers or usage-based billing.
• Customer acquisition or retention plans.

Not evidenced No evidence of a business model or pricing structure is provided. The project is described as a prototype and not intended for autonomous diagnosis, prescribing, ordering, triage, or treatment selection.

The author reports:

• Built with technologies including Caddy, FastAPI, Next.js, React, Docker, PostgreSQL, pgvector, TypeScript, Python, OpenAI, Codex.
• Implementation involved strict schema enforcement, server-side API handling, and safety controls.
• Use of feature flags, rate limits, deterministic regression tests, and local reproducibility.
• Integration with existing OrthoPath and OrthoRAG components without altering their authority boundaries.

The description states that OrthoSphere:

• Was developed by a solo clinician-developer.
• Includes components like OrthoPath and OrthoRAG that already existed.
• Added GPT-5.6 Evidence Brief during OpenAI Build Week.
• Is described as an “assistive prototype” not intended for autonomous use.

The description does not provide any information about:

• Competitors in the orthopaedic AI space.
• Market positioning relative to other tools.
• Differentiation from existing evidence synthesis platforms.
• Industry trends or regulatory considerations.

Not evidenced No competitive analysis or market context is included. The project appears to be self-contained and not part of a broader competitive landscape.

Key risks and red flags based on the description:

• Single-person development: The platform is built by one person, raising concerns about scalability, maintenance, and long-term viability.
• Prototype status: Described as an “assistive prototype,” not intended for autonomous use, suggesting limited commercial readiness.
• No external validation or feedback: No evidence of real-world testing or clinician input beyond the author’s own experience.
• Unverified model claims: The project is built around GPT-5.6, which is not a verified product; its capabilities are self-reported.
• Limited product scope: The new GPT-5.6 feature is isolated and does not integrate into broader clinical workflows or decision-making systems.

1. What specific orthopaedic clinical problems does OrthoSphere aim to solve, and how do you know?
2. How many clinicians have tested the platform beyond your own development experience?
3. Are there any plans for clinical validation or usability studies with actual users?
4. What is the long-term vision for integrating GPT-5.6 into existing orthopaedic workflows?
5. How does the platform plan to scale beyond a solo developer and prototype stage?
6. What are the technical and regulatory challenges in deploying such a system in real clinical settings?